Evanium
Regensburg, DE · 1 known investors
EVANIUM develops OPTISOLV®, an IP-protected drug-delivery technology that improves the water solubility, stability, absorption, and taste of plant-based active ingredients such as polyphenols and flavonoids. The technology is aimed at brands making food, nutraceutical, pharmaceutical, and personal care products, with development in Germany and production in Europe.
Founders & leadership
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountseed fundingApr 2026 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Evanium do?
- EVANIUM develops OPTISOLV®, an IP-protected drug-delivery technology that improves the water solubility, stability, absorption, and taste of plant-based active ingredients such as polyphenols and flavonoids. The technology is aimed at brands making food, nutraceutical, pharmaceutical, and personal care products, with development in Germany and production in Europe.
- Who founded Evanium?
- Evanium was founded by David Ofner, Felix Rolka.
- Who are Evanium's investors?
- Evanium's investors include FoodLabs.
- Where is Evanium headquartered?
- Evanium is headquartered in Regensburg, DE.